期刊文献+

慢性乙型肝炎患者血清学指标综合评价 被引量:7

The Total Estimation of Serum Indicator in Patients with Chronic Viral Heptatitis Type B
下载PDF
导出
摘要 目的全面检测慢性乙型肝炎(乙肝)患者各项血清学指标,以期筛选出更经济、实用的随访指标。方法用酶联免疫吸附试验检测260例慢性乙肝患者血清病毒标志物(HBV-M)、前S1抗原(PreS1-Ag),用荧光定量-聚合酶联反应方法检测HBV DNA含量,用全自动生化分析仪检测肝功能指标。结果慢性乙肝患者血清PreS1-Ag与HBV DNA拷贝数具有良好的正相关性;HBeAg阴性组PreS1-Ag阳性率为54.7%,HBV DNA阳性率为56.0%;慢性乙肝患者肝功能指标中的ALT、AST、TP、A/G、GGT阳性率较其他指标高,其中ALT阳性率最高(58%),AST次之(42%)。结论 PreS1-Ag与HBV DNA符合率较高,比HBeAg更能反应病毒复制情况,ALT、AST是较灵敏的肝功能指标。慢性乙肝患者可以PreS1-Ag、ALT及AST作为长期随访指标。 Objective In order to select economical and valuable follow-up indicator,all serum indicator of patients with chronic HBV were detected. Methods The HBV markers,PreS1-Ag were detected by ELISA in 260 patients with HBV. The level of HBV DNA were detected by fluorescence quantitative PCR. The level of liver function were obtained by an automated biochemistry analy- zer. Results No significant difference was found between the detectable rates of HBV DNA and PreS1 Ag in patients with chronic heptatitistry virus The positive rate of PreS1-Ag and HBV DNA were 54.7% and 56.0% in HBeAg-nagative group. Significant difference was found between the detectable rates of ALT, AST, TP, A/G, GGT in patient with HBV and the detectable rates of ALB,G,TBIL,DBIL,ALP. The positive rate of ALT and AST were 58% and 42.% respectively. Conclusion HBV PreS1-Ag closely correlates with HBV DNA. ALT and AST are the most sensitive liver function markers, the patients with chronic heptatitis B virus can select PreS1-Ag,ALT and AST as the long follow-up indicator.
出处 《国际检验医学杂志》 CAS 2011年第2期165-166,共2页 International Journal of Laboratory Medicine
关键词 肝炎病毒 乙型 肝功能试验 乙型肝炎病毒前S1抗原 heptatitis B virus liver function tests HBV PreS1-Ag
  • 相关文献

参考文献11

二级参考文献74

共引文献48

同被引文献66

  • 1郭华国,姚正国.脂质、血红蛋白、胆红素标本对乙肝病毒DNA荧光定量测定的影响[J].微循环学杂志,2006,16(1):32-33. 被引量:6
  • 2YokotaM,TatsumiN,Nathalang0,eta1.Effectsofheparinonpolymerasechainreactionforbloodwhitecells[J].JClinLabA-nal,1999,13(3):133-140.
  • 3KIM BK, HAN KH, AHN SH. Hepatitis B virus serology to predict antiviral response in chronic hepatitis B [ J ] . Digestion, 2011, 84 : 29 - 34.
  • 4COULION S, HEINDRYCX, F, GEERTS A, et al. Angiogenesis in chronic liver disease and its complications [J] . Liver Int, 2011, 31(2): 146-162.
  • 5VANHEULE E, GEERTS AM, VAN HUYSSE J, et al. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice mod- els: relationship between fibrosis and angiogenesis [J] . Int J Exp Pathol, 2008, 89 (6): 419-432.
  • 6VON MARSCHALL Z, CRAMER T, HOCKER M, et al. Dual mocha- nism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma [ J ] . Gut, 2001, 48 ( 1 ) : 87 - 96.
  • 7DRAFF A, WEINDDK OCHDS A, et al. Vascular endothelia growth factor in the sera and effusions of patients with malignant and non-ma- lignant disease [J] . Cancer, 1999, 85:178 -187.
  • 8郭燕萍,杨广英,王建君,等.肝组织中转化生长因子-B1、血管内皮生长因子及微血管密度的表达在肝纤维化中的作用及意义[J].中国实用医刊,2008,35(27):10-11.
  • 9JINNO K, WANG W, ELLIS L, et al. NF-Kappa B regulates VEGF gene expression in human pancreatic cancers [ J ]. Proc Annu Meet Am Assoc Res, 1996, 37 (4) : 525 -530.
  • 10GADELHAK NA, GADELHAK SA, EL-MORSI DA, et al. Prognostic significance of three hepatitis markers ( p53 antibod- ies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma [ J] . Hepatogastmenterolo- gy, 2009, 56 (94-95): 1417-1424.

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部